There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Courts have long deferred to CMS’s decisions on implementation of laws that govern Medicare. The overturning of the Chevron ...